Welltower (NYSE:WELL – Get Free Report) had its price objective boosted by analysts at Deutsche Bank Aktiengesellschaft from $215.00 to $265.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the real estate investment trust’s stock. Deutsche Bank Aktiengesellschaft’s target price points to a potential upside of 14.87% from the stock’s current price.
Several other research firms have also issued reports on WELL. Wall Street Zen raised Welltower from a “sell” rating to a “hold” rating in a report on Saturday, May 2nd. UBS Group boosted their price objective on Welltower from $240.00 to $249.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Mizuho set a $239.00 price objective on Welltower in a research report on Friday, May 22nd. Jefferies Financial Group upped their price objective on Welltower from $237.00 to $248.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Finally, Scotiabank decreased their target price on Welltower from $248.00 to $232.00 and set a “sector outperform” rating for the company in a research report on Thursday, June 18th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $232.29.
View Our Latest Analysis on WELL
Welltower Stock Up 1.6%
Welltower (NYSE:WELL – Get Free Report) last issued its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $1.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.68 by $0.34. Welltower had a net margin of 11.96% and a return on equity of 3.45%. The business had revenue of $3.35 billion during the quarter, compared to the consensus estimate of $3.12 billion. During the same period in the prior year, the firm posted $1.20 EPS. The firm’s quarterly revenue was up 38.3% compared to the same quarter last year. Welltower has set its FY 2026 guidance at 6.210-6.350 EPS. On average, equities analysts forecast that Welltower will post 6.32 EPS for the current year.
Institutional Trading of Welltower
A number of large investors have recently bought and sold shares of the company. Leonteq Securities AG grew its stake in shares of Welltower by 92.3% during the 1st quarter. Leonteq Securities AG now owns 125 shares of the real estate investment trust’s stock worth $25,000 after acquiring an additional 60 shares during the period. Sound Income Strategies LLC raised its stake in Welltower by 124.6% in the 1st quarter. Sound Income Strategies LLC now owns 137 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 76 shares during the period. Marquette Asset Management LLC raised its stake in Welltower by 62.8% in the 4th quarter. Marquette Asset Management LLC now owns 153 shares of the real estate investment trust’s stock valued at $28,000 after acquiring an additional 59 shares during the period. Swiss RE Ltd. bought a new stake in Welltower in the 4th quarter valued at about $29,000. Finally, Financial Consulate Inc. purchased a new stake in Welltower during the fourth quarter valued at about $34,000. 94.80% of the stock is owned by hedge funds and other institutional investors.
Welltower Company Profile
Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.
The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.
Further Reading
- Five stocks we like better than Welltower
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
- Hershey Stock May Be Near a Sweet Spot as Cocoa Pressure Eases
- Comcast’s NBCUniversal Split Puts Broadband Back in Focus
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.
